BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 17474154)

  • 1. Role of TGF-beta and PGE2 in T cell responses during Plasmodium yoelii infection.
    Ocaña-Morgner C; Wong KA; Lega F; Dotor J; Borras-Cuesta F; Rodriguez A
    Eur J Immunol; 2007 Jun; 37(6):1562-74. PubMed ID: 17474154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model.
    Doolan DL; Hoffman SL
    J Immunol; 1999 Jul; 163(2):884-92. PubMed ID: 10395683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium yoelii in mice: antigen reactivity of CD4- and CD8-bearing T cells.
    Lucas B; Engel A; Camus D; Haque A
    Cell Immunol; 1993 Aug; 150(1):59-71. PubMed ID: 8102089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escheriosome entrapped soluble blood stage antigens impart protective immunity against a multi-drug resistant isolate of Plasmodium yoelii nigeriensis in BALB/c mice.
    Sharma SK; Farah D; Misra-Bhattacharya S; Bajpai P; Agarwal A; Mohammad O
    Vaccine; 2006 Feb; 24(7):948-56. PubMed ID: 16168527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive transfer of CD8+ T cells from immune animals does not transfer immunity to blood stage Plasmodium yoelii malaria.
    Vinetz JM; Kumar S; Good MF; Fowlkes BJ; Berzofsky JA; Miller LH
    J Immunol; 1990 Feb; 144(3):1069-74. PubMed ID: 1967271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells can initiate protective immune responses against malaria.
    Bruña-Romero O; Rodriguez A
    Infect Immun; 2001 Aug; 69(8):5173-6. PubMed ID: 11447201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of CD8+ T cells in protective immunity against murine blood-stage infection with Plasmodium yoelii 17XL strain.
    Imai T; Shen J; Chou B; Duan X; Tu L; Tetsutani K; Moriya C; Ishida H; Hamano S; Shimokawa C; Hisaeda H; Himeno K
    Eur J Immunol; 2010 Apr; 40(4):1053-61. PubMed ID: 20101613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium berghei XAT: contribution of gammadelta T cells to host defense against infection with blood-stage nonlethal malaria parasite.
    Kobayashi F; Niikura M; Waki S; Matsui T; Fujino T; Tsuruhara T; Kamiya S
    Exp Parasitol; 2007 Dec; 117(4):368-75. PubMed ID: 17601562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium yoelii: peptide immunization induces protective CD4+ T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein.
    Takita-Sonoda Y; Tsuji M; Kamboj K; Nussenzweig RS; Clavijo P; Zavala F
    Exp Parasitol; 1996 Nov; 84(2):223-30. PubMed ID: 8932772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
    Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
    J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
    White KL; Snyder HL; Krzych U
    J Immunol; 1996 May; 156(9):3374-81. PubMed ID: 8617963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent infection with Heligmosomoides polygyrus suppresses anti-Plasmodium yoelii protection partially by induction of CD4(+)CD25(+)Foxp3(+) Treg in mice.
    Tetsutani K; Ishiwata K; Ishida H; Tu L; Torii M; Hamano S; Himeno K; Hisaeda H
    Eur J Immunol; 2009 Oct; 39(10):2822-30. PubMed ID: 19728313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
    Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
    J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct host-related dendritic cell responses during the early stage of Plasmodium yoelii infection in susceptible and resistant mice.
    Zheng W; Wang QH; Liu YJ; Liu J; Feng H; Wu JJ; Cao YM
    Parasite Immunol; 2010 May; 32(5):324-34. PubMed ID: 20500661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient development of plasmodium liver stage-specific memory CD8+ T cells during the course of blood-stage malarial infection.
    Hafalla JC; Rai U; Bernal-Rubio D; Rodriguez A; Zavala F
    J Infect Dis; 2007 Dec; 196(12):1827-35. PubMed ID: 18190264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii.
    Keswani T; Bhattacharyya A
    Exp Parasitol; 2014 Jun; 141():82-92. PubMed ID: 24675415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C; Rogers WO; Gowda K; Doolan DL
    Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of regulatory T cells to glucocorticoid-induced [corrected] TNFR family-related protein (GITR) during Plasmodium yoelii infection.
    Hisaeda H; Hamano S; Mitoma-Obata C; Tetsutani K; Imai T; Waldmann H; Himeno K; Yasutomo K
    Eur J Immunol; 2005 Dec; 35(12):3516-24. PubMed ID: 16304635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The shiitake mushroom-derived immuno-stimulant lentinan protects against murine malaria blood-stage infection by evoking adaptive immune-responses.
    Zhou LD; Zhang QH; Zhang Y; Liu J; Cao YM
    Int Immunopharmacol; 2009 Apr; 9(4):455-62. PubMed ID: 19189863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.